Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Apiam Animal Health's 3-Year RORE % for the quarter that ended in Jun. 2025 was -72.73%.
The industry rank for Apiam Animal Health's 3-Year RORE % or its related term are showing as below:
ASX:AHX's 3-Year RORE % is not ranked
in the Personal Services industry.
Industry Median: 4.86
vs ASX:AHX: -72.73
Apiam Animal Health (ASX:AHX) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Apiam Animal Health 3-Year RORE % Related Terms
Apiam Animal Health 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Apiam Animal Health's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:AHX vs ROL, SCI, BFAM: 3-Year RORE % Comparison
For the Personal Services subindustry, Apiam Animal Health's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apiam Animal Health 3-Year RORE % vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Apiam Animal Health's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Apiam Animal Health's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jun. 2025 and 3-year before.
Apiam Animal Health (ASX:AHX) has a 3-Year RORE % of -72.73 as of Jun. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Apiam Animal Health and its competitors.
Is Apiam Animal Health's 3-Year RORE % too high?
Apiam Animal Health's current 3-Year RORE % is -72.73. Overall, Apiam Animal Health has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Apiam Animal Health's 3-Year RORE % compare to ROL and SCI?
Apiam Animal Health's 3-Year RORE % of -72.73 can be compared against companies in the Personal Services industry. The industry median 3-Year RORE % is 4.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Personal Services company?
The median 3-Year RORE % among Personal Services companies is 4.86, based on 90 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Apiam Animal Health and its competitors. For the Personal Services industry, the median 3-Year RORE % is 4.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apiam Animal Health's current 3-Year RORE % is -72.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apiam Animal Health stock overvalued right now?
Apiam Animal Health (ASX:AHX) has a current 3-Year RORE % of -72.73. The stock's GF Value™ is A$0.40, compared to a current price of A$0.88 — trading 118.8% above its estimated fair value. The current 3-Year RORE % is -72.73. Apiam Animal Health's overall GF Score™ is 50/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Apiam Animal Health (ASX:AHX), the current 3-Year RORE % is -72.73 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apiam Animal Health (ASX:AHX) Overvalued in 2026?
Based on GuruFocus' analysis, Apiam Animal Health stock appears to be overvalued.
The current stock price of A$0.88 is trading 118.8% above its estimated GF Value™ of A$0.40.
Key valuation signals for ASX:AHX:
3-Year RORE %: -72.73
GF Value™: A$0.40 vs. price of A$0.88 (118.8% above fair value)
No single metric tells the full story. See the ASX:AHX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apiam Animal Health Ltd provides products and services to support the health and welfare of production and mixed animals. The company offers veterinary wholesale, warehousing, logistics, and other ancillary services. Its operating segments include Dairy and Mixed, Feedlots and Pigs. It generates the majority of its revenue from Dairy and Mixed. The Group operates in the segment of provision of veterinary products and services to production, companion and equine animals.
50GF Score
Get the complete analysis for ASX:AHX
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AHX has been successfully added to your 
